
Company created by Palmer Luckey and Ben Lamm wants to rebuild the national breeding stock of working dogs for military and security use
Texan startup Warhound raised US$200 million, valuing the company at US$1.2 billion, to produce genetically enhanced military dogs equipped with advanced technology for the battlefield.
AI-generated summary
Warhound was designed to produce genetically improved working dogs and fill a shortage in the American breeding stock, which currently depends on European breeders.
San Francisco | Financial Times A Texas-based startup that promises to give the United States an edge on the battlefield by rebuilding the nation's roster of "military working dogs" has raised $200 million from investors including Sequoia Capital and Ark Invest.
Warhound, the brainchild of Anduril co-founder Palmer Luckey and software entrepreneur Ben Lamm, will "produce genetically enhanced working dogs" on U.S. soil and equip them with advanced technology to ensure they have "situational awareness on the battlefield," the new company said.
Warhound was valued at US$1.2 billion in its fundraising round, including the new investment, according to a person familiar with the operation.
Lamm, who conceived the plan with Luckey 18 months ago, described it as a "Captain America program for dogs [that] also solves a real problem related to the welfare of these animals."
The eccentric startup has attracted interest from some of the biggest names in Silicon Valley and other financial centers, including Sequoia, Lux Capital, Franklin Templeton and In-Q-Tel, a venture capital firm created by the CIA that invests in early-stage technology companies with direct application to intelligence and national security operations.
Lamm's company, Colossal Biosciences, works in species preservation, animal cloning and "de-extinction," which it defines as "a practical application of advanced gene-editing technology aimed at reconstructing the DNA of extinct megafauna." The company claims to be in the process of promoting the "de-extinction of the woolly mammoth".
Its technology will be used to clone and genetically edit working dogs, in a move that Lamm says would improve performance and be more humane for the animals, many of which are currently unable to complete training.
"Our idea is: select the best dogs, store their material in a biobank and clone them... In addition to cloning the dogs, it would be possible to genetically edit them and increase their longevity and performance. This is healthier for the dog, the firefighter, the police officer or the combatant", said Lamm, who will join the company's board of directors.
Anduril, a maker of autonomous drones, submarines and other military vehicles — and one of the United States' best-known defense technology startups — will develop body armor and "cyber" systems to improve dogs' performance.
"Man's best friend deserves man's best technology," said Luckey, who will have no ownership stake in Warhound nor will he play any role in the day-to-day management of the company.
Warhound will be led by David Spirk, a former US Marine, the Pentagon's first chief data officer and former senior advisor at Palantir Technologies.
The company aims to boost the national supply of working dogs, the majority of which currently come from European breeders.
Spirk said, "Leading Warhound and strengthening America's capacity to employ working dogs is an opportunity to apply my experience to a mission I care deeply about: protecting people and helping the animals that support them."
AI outlook — possibilities, not facts
Warhound will produce cloned and genetically edited dogs
Likely · Within months

Tech giants invest trillions in AI, raising fears of a financial bubble. A Deloitte expert points out that the lack of clear metrics to measure gains makes it difficult to perceive value, but predicts greater clarity in results from 2025 onwards.

Four months after the end of the self-composition commission, the agreement for the concession of Viracopos Airport, in Campinas, remains pending approvals from AGU and Anac, with slow negotiations due to the electoral period.

More than 22,200 individual microentrepreneurs in Acre can benefit from the Prospera MEI program, sanctioned by President Lula. The measure includes debt forgiveness, an increase in the annual revenue ceiling and facilities for public purchases.

Members of the Public Ministry claim that the explosion of fraud in investment funds in Brazil is due to failures in CVM supervision and the slowness in referring cases to the criminal sphere, and not due to a lack of rules.

BNDES approved R$298 million in financing for the pharmaceutical company Althaia to develop new medicines, including research with new molecules, artificial intelligence and 31 new products.

J.P. Morgan analysts project 15% annual growth in the GLP-1 drug market in Brazil, China and India until 2035, driven by the high prevalence of diabetes and obesity and greater accessibility to treatments.